Your browser doesn't support this page

This website uses the latest technology, and it looks like your browser doesn't support some of the latest features.

You'll probably be able to see the content with the browser you have, but we encourage you to choose a browser with better support for the future of the web. These support all the features used (and they're free too):

Google Chrome Mozilla Firefox Safari Dismiss

Research Goals

Our research is focused on large scale genomic instability in cancer. Our aim is to understand the process of changes in DNA- and chromatin structure during cancer development, and to use this knowledge to predict treatment response and prognosis for cancer patients.

Imaging Research

Microscopic images of cell nuclei from different sources (Light microscopy, Laser Scan microscopy, Electron micro- scopy & digital scanners) are digitally processed and analyzed. Methods and applications are developed to process very large amounts of image data for quantitative and qualitative analysis of DNA- and chromatin structure.

Cancer Focus

The Institute is conducting basic research in both biomedicine and informatics, has a number of projects in translational/clinical research, and several development projects on supportive clinical tools. Our biomedical and clinical research is focused on cancer, whereas the development projects are more general.

Prognostic Markers

Our main research hypothesis is that genomic instability is a driving force in cancer, and the ability to identify and measure genomic instability might therefore be useful markers in predictive diagnosis and prognosis. Our key projects here are Nucleotyping, DNA ploidy, Microtracker, 3D-imaging, TMA and Path Tool.

Research projects

Chief Editor: Prof. HÃ¥vard E. Danielsen
Copyright Oslo University Hospital. Visiting address: The Norwegian Radium Hospital, Ullernchausséen 64, Oslo. Tel: 22 78 23 20